Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Dendritic cells and innate defense against tumor cells.

Ullrich E, Ménard C, Flament C, Terme M, Mignot G, Bonmort M, Plumas J, Chaperot L, Chaput N, Zitvogel L.

Cytokine Growth Factor Rev. 2008 Feb;19(1):79-92. Epub 2007 Dec 26. Review.

PMID:
18155952
2.

Links between innate and cognate tumor immunity.

Ghiringhelli F, Apetoh L, Housseau F, Kroemer G, Zitvogel L.

Curr Opin Immunol. 2007 Apr;19(2):224-31. Epub 2007 Feb 15. Review.

PMID:
17303400
3.

Cytokines in innate and adaptive immunity.

Banyer JL, Hamilton NH, Ramshaw IA, Ramsay AJ.

Rev Immunogenet. 2000;2(3):359-73. Review.

PMID:
11256745
4.

Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.

Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T.

J Leukoc Biol. 2008 Sep;84(3):679-88. doi: 10.1189/jlb.1107729. Epub 2008 Jun 19.

PMID:
18566103
5.

IFN-alpha in the generation of dendritic cells for cancer immunotherapy.

Santini SM, Lapenta C, Santodonato L, D'Agostino G, Belardelli F, Ferrantini M.

Handb Exp Pharmacol. 2009;(188):295-317. doi: 10.1007/978-3-540-71029-5_14. Review.

PMID:
19031032
6.

Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC).

Bonmort M, Ullrich E, Mignot G, Jacobs B, Chaput N, Zitvogel L.

Biochimie. 2007 Jun-Jul;89(6-7):872-7. Epub 2007 May 5. Review.

PMID:
17574720
7.

Molecular characteristics of immunogenic cancer cell death.

Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G.

Cell Death Differ. 2008 Jan;15(1):3-12. Epub 2007 Nov 16. Review.

8.

Dendritic cells and cytokines in immune rejection of cancer.

Ferrantini M, Capone I, Belardelli F.

Cytokine Growth Factor Rev. 2008 Feb;19(1):93-107. Epub 2007 Dec 3. Review.

PMID:
18054517
9.

Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.

Fujii S.

Trends Immunol. 2008 May;29(5):242-9. doi: 10.1016/j.it.2008.02.002. Epub 2008 Mar 26. Review.

PMID:
18372215
10.

Innate and adaptive immune pathways to tolerance.

Thornton CA, Morgan G.

Nestle Nutr Workshop Ser Pediatr Program. 2009;64:45-57; discussion 57-61, 251-7. doi: 10.1159/000235782. Epub 2009 Aug 19.

PMID:
19710514
11.

Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.

Reschner A, Hubert P, Delvenne P, Boniver J, Jacobs N.

Clin Exp Immunol. 2008 May;152(2):219-26. doi: 10.1111/j.1365-2249.2008.03624.x. Epub 2008 Mar 10. Review. Erratum in: Clin Exp Immunol. 2008 Sep;153(3):463.

12.

Tumor stress, cell death and the ensuing immune response.

Ullrich E, Bonmort M, Mignot G, Kroemer G, Zitvogel L.

Cell Death Differ. 2008 Jan;15(1):21-8. Epub 2007 Nov 9. Review.

13.

Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?

Shurin MR, Shurin GV, Lokshin A, Yurkovetsky ZR, Gutkin DW, Chatta G, Zhong H, Han B, Ferris RL.

Cancer Metastasis Rev. 2006 Sep;25(3):333-56. Review.

PMID:
17029028
14.

The dendritic cell-tumor cross-talk in cancer.

Ma Y, Aymeric L, Locher C, Kroemer G, Zitvogel L.

Curr Opin Immunol. 2011 Feb;23(1):146-52. doi: 10.1016/j.coi.2010.09.008. Epub 2010 Oct 21. Review.

PMID:
20970973
15.

CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans.

Haining WN, Davies J, Kanzler H, Drury L, Brenn T, Evans J, Angelosanto J, Rivoli S, Russell K, George S, Sims P, Neuberg D, Li X, Kutok J, Morgan J, Wen P, Demetri G, Coffman RL, Nadler LM.

Clin Cancer Res. 2008 Sep 1;14(17):5626-34. doi: 10.1158/1078-0432.CCR-08-0526.

16.

Dendritic cells from bench to bedside and back.

Adema GJ.

Immunol Lett. 2009 Feb 21;122(2):128-30. doi: 10.1016/j.imlet.2008.11.017. Epub 2008 Dec 31. Review.

PMID:
19121337
17.

Cytokine gene-mediated immunotherapy: current status and future perspectives.

Jinushi M, Tahara H.

Cancer Sci. 2009 Aug;100(8):1389-96. doi: 10.1111/j.1349-7006.2009.01202.x. Epub 2009 May 13. Review.

18.

Imatinib mesylate--uncovering a fast track to adaptive immunity.

Smyth MJ.

N Engl J Med. 2006 May 25;354(21):2282-4. No abstract available.

PMID:
16723621
19.

[Innate defence against tumor cells: the killer cell IKDC].

Chaput N, Taieb J, Zitvogel L.

Bull Cancer. 2006 May;93(5):449-51. French.

20.

Killer dendritic cells and their potential role in immunotherapy.

Ullrich E, Chaput N, Zitvogel L.

Horm Metab Res. 2008 Feb;40(2):75-81. doi: 10.1055/s-2007-1022554. Review.

PMID:
18283624

Supplemental Content

Support Center